Publication | Closed Access

Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent

Viral HepatitisAntiviral TherapyHepatitisVirologyCombination TherapyInfection ControlAntiviral DrugMedicineAntiviral CompoundDirect-acting Antiviral Agent